IN2014DN06198A - - Google Patents
Info
- Publication number
- IN2014DN06198A IN2014DN06198A IN6198DEN2014A IN2014DN06198A IN 2014DN06198 A IN2014DN06198 A IN 2014DN06198A IN 6198DEN2014 A IN6198DEN2014 A IN 6198DEN2014A IN 2014DN06198 A IN2014DN06198 A IN 2014DN06198A
- Authority
- IN
- India
- Prior art keywords
- tablet
- present
- tablets
- hardness
- eliminate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Aspects of the present invention are directed to an oral antacid tablet comprising at least about 60% by weight directly compressible granulated calcium carbonate and an intense flavoring. The tablet may have a hardness of at least about 22 Strong Cobb units and the tablet may have a mass of between about 500 mg and about 1 000 mg. Tablets of the present invention reduce or eliminate heartburn symptoms and also freshen breath.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261594055P | 2012-02-02 | 2012-02-02 | |
PCT/US2013/024078 WO2013116477A1 (en) | 2012-02-02 | 2013-01-31 | Antacid tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN06198A true IN2014DN06198A (en) | 2015-10-23 |
Family
ID=48905820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6198DEN2014 IN2014DN06198A (en) | 2012-02-02 | 2013-01-31 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20140037759A1 (en) |
EP (1) | EP2809331A4 (en) |
CN (1) | CN104136033A (en) |
AR (1) | AR089857A1 (en) |
BR (1) | BR112014019155A8 (en) |
CA (1) | CA2863389A1 (en) |
CO (1) | CO7020922A2 (en) |
HK (1) | HK1201179A1 (en) |
IN (1) | IN2014DN06198A (en) |
MX (1) | MX2014009391A (en) |
WO (1) | WO2013116477A1 (en) |
ZA (1) | ZA201405354B (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ243567A (en) * | 1991-07-22 | 1995-04-27 | Bristol Myers Squibb Co | Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition |
GB9825033D0 (en) * | 1998-11-13 | 1999-01-13 | Nycomed Pharma As | Process |
US6358526B1 (en) * | 2000-08-16 | 2002-03-19 | Rexall Sundown | Method of making tablets and tablet compositions produced therefrom |
EP1596821A2 (en) * | 2003-01-24 | 2005-11-23 | The State Of Israel-Ministry Of Agriculture | Synergistic compositions and methods for potentiating anti-oxidative activity |
CA2514875A1 (en) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories International Srl | Rapid absorption selective 5-ht agonist formulations |
UA95093C2 (en) * | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Method for the preparation of calcium-containing compound |
WO2007134158A2 (en) * | 2006-05-12 | 2007-11-22 | Drugtech Corporation | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy |
-
2013
- 2013-01-30 AR ARP130100289A patent/AR089857A1/en unknown
- 2013-01-31 EP EP13743888.3A patent/EP2809331A4/en not_active Ceased
- 2013-01-31 IN IN6198DEN2014 patent/IN2014DN06198A/en unknown
- 2013-01-31 US US13/755,229 patent/US20140037759A1/en not_active Abandoned
- 2013-01-31 BR BR112014019155A patent/BR112014019155A8/en not_active IP Right Cessation
- 2013-01-31 MX MX2014009391A patent/MX2014009391A/en unknown
- 2013-01-31 CN CN201380010222.5A patent/CN104136033A/en active Pending
- 2013-01-31 CA CA2863389A patent/CA2863389A1/en not_active Abandoned
- 2013-01-31 WO PCT/US2013/024078 patent/WO2013116477A1/en active Application Filing
-
2014
- 2014-07-21 ZA ZA2014/05354A patent/ZA201405354B/en unknown
- 2014-07-31 CO CO14167105A patent/CO7020922A2/en unknown
-
2015
- 2015-02-13 HK HK15101650.2A patent/HK1201179A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1201179A1 (en) | 2015-08-28 |
ZA201405354B (en) | 2015-11-25 |
BR112014019155A2 (en) | 2017-06-20 |
US20140037759A1 (en) | 2014-02-06 |
CN104136033A (en) | 2014-11-05 |
EP2809331A4 (en) | 2015-07-15 |
EP2809331A1 (en) | 2014-12-10 |
CA2863389A1 (en) | 2013-08-08 |
AR089857A1 (en) | 2014-09-24 |
CO7020922A2 (en) | 2014-08-11 |
MX2014009391A (en) | 2014-08-27 |
WO2013116477A1 (en) | 2013-08-08 |
BR112014019155A8 (en) | 2017-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
MY159630A (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof | |
HK1147202A1 (en) | Orally disintegrated dosage form | |
UA97489C2 (en) | Pharmaceutical composition containing amorphous rosuvastatin calcium | |
UA92641C2 (en) | Pharmaceutical composition comprising amlodipine and losartan | |
MY187718A (en) | Pharmaceutical formulations | |
MX2009009153A (en) | Pyrano-pyrazole-amines. | |
MX2017000827A (en) | Sugar compositions for tableting by direct compression. | |
MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
MX2010001705A (en) | Co-crystals of pyrimethanil and dithianon. | |
TN2012000507A1 (en) | Enteric tablet | |
UA92077C2 (en) | Orodispersible domperidone tablets | |
TN2010000585A1 (en) | Pharmaceutical compositions of rosuvastatin calcium | |
IN2014MN01382A (en) | ||
IN2014DN06198A (en) | ||
MX2012002209A (en) | Controlled-release formulations of anabaseine compounds and uses thereof. | |
ATE525064T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE | |
ES2482342A1 (en) | Therapeutic treatment of t- and b-acute lymphoblastic leukemia and human lymphomas by inhibition of the interleukin-7 receptor (il-7r) | |
UA88127C2 (en) | Tablet for prevention and treatment of dental and periodontium diseases | |
MX2011009844A (en) | Pharmaceutical composition comprising aliskiren. | |
PH12019501070A1 (en) | Sustained-release dosage forms of ruxolitinib | |
GR1007225B (en) | Pharmaceutical composition of intestine-soluble tablets of trihydrate magnesium aspartate hydrochloride | |
UA105167C2 (en) | Perindopril calcium salt or solvate thereof | |
MX2010000624A (en) | Methods for promoting wakefulness. | |
UA99199C2 (en) | Pharmaceutical compositions of rosuvastatin calcium |